Stockreport

1 Beaten-Down Stock With 55% Upside, According to Wall Street [Yahoo! Finance]

Editas Medicine, Inc.  (EDIT) 
Last editas medicine, inc. earnings: 2/26 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.editasmedicine.com
PDF That's the case with Editas Medicine (NASDAQ: EDIT) , a clinical-stage gene editing-focused biotech company. However, many analysts on Wall Street have high hopes for [Read more]